Table 1.
Laboratory test results.
| Variable | Measurements | Reference range |
|---|---|---|
| Red-cell count (×10^6/μL) | 4.32 | 3.86–4.92 |
| Hemoglobin (g/dL) | 13.1 | 11.6–14.8 |
| Hematocrit (%) | 37.2 | 35.1–44.4 |
| Platelet count (×10^3/μL) | <1 | 158–148 |
| White-cell count (/μL) | 3.6 | 3.3–8.6 |
| Stab cell (%) | 1.5 | 2.0–13.0 |
| Segmented cell (%) | 56.0 | 38.0–58.9 |
| Lymphocytes (%) | 37.0 | 26.0–46.6 |
| Monocytes (%) | 3.5 | 2.3–7.7 |
| Eosinophils (%) | 0.5 | 0.0–5.0 |
| Atypical lymphocytes (%) | 1.5 | 0.0 |
| Aspartate aminotransferase (U/L) | 20 | 13–30 |
| Alanine aminotransferase (U/L) | 15 | 7–30 |
| Lactate dehydrogenase (U/L) | 160 | 124–222 |
| Alkaline phosphatase (U/L) | 52 | 38–113 |
| γ-glutamyl transpeptidase (U/L) | 12 | 9–32 |
| Total bilirubin (mg/dL) | 1.1 | 0.4–1.2 |
| Direct bilirubin (mg/dL) | 0.1 | ≤0.2 |
| Total protein (g/dL) | 7.7 | 6.6–8.1 |
| Albumin (g/dL) | 4.6 | 4.1–5.1 |
| Cholinesterase (U/L) | 298 | 201–421 |
| Urea nitrogen (mg/dL) | 9 | 8–20 |
| Creatinine (mg/dL) | 0.44 | 0.46–0.79 |
| Sodium (mmol/L) | 140 | 138–145 |
| Potassium (mmol/L) | 3.4 | 3.6–4.8 |
| Chloride (mmol/L) | 104 | 101–108 |
| Calcium (mg/dL) | 9.0 | 8.8–10.1 |
| Uric acid (mg/dL) | 2.1 | 2.6–7.0 |
| C-reactive protein (mg/dL) | 0.04 | ≤0.14 |
| Iron (μg/dL) | 77 | 40–188 |
| Unsaturated iron-binding capacity (μg/dL) | 193 | 191–269 |
| Ferritin (ng/mL) | 92.4 | 10.0–60.0 |
| Immunoglobulin G (mg/dL) | 1705 | 861–1747 |
| Immunoglobulin A (mg/dL) | 121 | 93–393 |
| Immunoglobulin M (mg/dL) | 83 | 50–269 |
| Prothrombin time (seconds) | 12.5 | |
| International normalized ratio | 0.96 | 0.85–1.15 |
| Activated partial-thromboplastin time (seconds) | 29.9 | 24.0–39.0 |
| Fibrinogen (mg/dL) | 316 | 200–400 |
| Fibrin degradation products (μg/mL) | <2.5 | <5.0 |
| Antithrombin activity (%) | 110 | 80–130 |
| Complement component 3 (mg/dL) | 92 | 73–138 |
| Complement component 4 (mg/dL) | 29 | ≤15 |
| Antinuclear antibody (times) | 40 | <40 |
| Rheumatoid factor (IU/mL) | <1 | ≤15 |
| Anticardiolipin antibody IgG (U/mL) | ≤8 | <10.0 |
| Anticardiolipin β2-glycoprotein complex antibody (U/mL) | ≤1.2 | <3.5 |
| Platelet-associated IgG (ng/10^7 cells) | 1880 | ≤46 |
| Platelet factor 4-heparin complex antibody (U/mL) | <0.6 | <1.0 |
| Antiplatelet factor 4 (ng/mL) | 2 | ≤20 |
| Hepatitis B surface antigen | (−) | (−) |
| Hepatitis B core antibody | (−) | (−) |
| Hepatitis C antibody | (−) | (−) |
| Helicobacter pylori antibody IgG (U/mL) | 3 | <10.0 |